Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Mirogabalin Besylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 10,727Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Daiichi Sankyo nabs Japanese approval for Tarlige tablets in neuropathic pain
    Daiichi Sankyo nabs Japanese approval for Tarlige tablets in neuropathic pain

    29 Mar 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=147752&sid=2

    PHARMABIZ
    29 Mar 2022
    Share Share
    Menarini to commercialize Japanese drug in Singapore, Malaysia, and Philippines
    Menarini to commercialize Japanese drug in Singapore, Malaysia, and Philippines

    23 Aug 2021

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/18875/menarini-to-commercialize-japanese-drug-in-singapore-malaysia-and-the-philippines.html

    BIOSPECTRUM ASIA
    23 Aug 2021
    Share Share
    Daiichi Sankyo Announces Ph 3 Study Results of mirogabalin
    Daiichi Sankyo Announces Ph 3 Study Results of mirogabalin

    18 Dec 2020

    // RUTERS

    https://www.daiichisankyo.com/media/press_release/detail/index_4107.html

    RUTERS
    18 Dec 2020
    Share Share
    Daiichi Sankyo Announces Phase 3 Study Results of mirogabalin
    Daiichi Sankyo Announces Phase 3 Study Results of mirogabalin

    18 Dec 2020

    // DAIICHISANKYO

    https://www.daiichisankyo.com/media/press_release/detail/index_4107.html

    DAIICHISANKYO
    18 Dec 2020
    Share Share
    Daiichi Sankyo starts mirogabalin trial in spinal injury pain
    Daiichi Sankyo starts mirogabalin trial in spinal injury pain

    28 Mar 2019

    // Phil Taylor PMLIVE

    http://www.pmlive.com/pharma_news/daiichi_sankyo_starts_mirogabalin_trial_in_spinal_injury_pain_1282805

    Phil Taylor PMLIVE
    28 Mar 2019
    Share Share